Cargando…

SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis

BACKGROUND: Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the composite of heart failure (HF) hospitalizations or cardiovascular mortality among patients with HF. However, the efficacy of SGLT2 inhibitors in secondary endpoints of randomized trials and in subgroups of HF patients is not w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Rhanderson, Graffunder, Fabrissio P., Ternes, Caique M.P., Fernandes, Amanda, Rocha, Ana V., Fernandes, Gilson, Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257984/
https://www.ncbi.nlm.nih.gov/pubmed/34308311
http://dx.doi.org/10.1016/j.eclinm.2021.100933